<DOC>
	<DOC>NCT00192842</DOC>
	<brief_summary>The study hypotheasis is that curcumin, a natural compound with a potent antiproliferative effect, can improve the efficacy of the standard chemotherapy gemcitabine in patients with advanced pancreatic cancer. That is why the patients are given a daily oral dose of 8 gr of curcumin along the chemotherapeutic protocol of weekly gemcitabine.</brief_summary>
	<brief_title>Gemcitabine With Curcumin for Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>locally advanced or metastatic adenocarcinoma of the pancreas no prior chemotherapy performance status 02 adequate hematology and chemistry serious concurrent medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>carcinoma</keyword>
	<keyword>pancreas</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>curcumin</keyword>
</DOC>